Drug Manufacturers During the model pre-implementation period in early 2026, CMS negotiated with Novo Nordisk and Eli Lilly to come to agreement on the key parameters of the model, including details about pricing of the model drugs, cost sharing, rebate calculations, access policies (i.e., coverage criteria and prior authorization policies), the length of the agreement, data sharing arrangements, and agreement on lifestyle supports that will be offered
Found offers brand-name GLP-1s (like Wegovy, Zepbound, and Ozempic), oral options like Rybelsus, and compounded semaglutide, though compounded versions arent FDA-approved and may not be available in your state
H., Cullen, M
For the complete program registry, see ClinicalTrials.gov
Reducing ultra-processed food intake improves insulin sensitivity independently, potentially amplifying semaglutide metabolic effects
Clinical data on semaglutide microdosing is limited